The stock of Aspira Women’s Health Inc (AWH) has gone up by 13.62% for the week, with a 5.45% rise in the past month and a -38.99% drop in the past quarter. The volatility ratio for the week is 8.98%, and the volatility levels for the past 30 days are 8.56% for AWH. The simple moving average for the past 20 days is 12.27% for AWH’s stock, with a -64.32% simple moving average for the past 200 days.
Is It Worth Investing in Aspira Women’s Health Inc (NASDAQ: AWH) Right Now?
The stock has a 36-month beta value of 1.46. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 0 as “overweight,” 2 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for AWH is 11.07M, and at present, short sellers hold a 4.00% of that float. On October 17, 2024, the average trading volume of AWH was 77.60K shares.
AWH) stock’s latest price update
Aspira Women’s Health Inc (NASDAQ: AWH) has experienced a rise in its stock price by 15.93 compared to its previous closing price of 0.78. However, the company has seen a gain of 13.62% in its stock price over the last five trading days. globenewswire.com reported 2024-10-15 that New York State Department of Health (NYSDOH) Clinical Laboratory Evaluation (CLEP) approval allows for OvaWatch® to be marketed in New York State New York State Department of Health (NYSDOH) Clinical Laboratory Evaluation (CLEP) approval allows for OvaWatch® to be marketed in New York State
Analysts’ Opinion of AWH
Many brokerage firms have already submitted their reports for AWH stocks, with Cantor Fitzgerald repeating the rating for AWH by listing it as a “Overweight.” The predicted price for AWH in the upcoming period, according to Cantor Fitzgerald is $4 based on the research report published on January 12, 2022 of the previous year 2022.
Truist, on the other hand, stated in their research note that they expect to see AWH reach a price target of $12. The rating they have provided for AWH stocks is “Buy” according to the report published on March 29th, 2021.
Cantor Fitzgerald gave a rating of “Overweight” to AWH, setting the target price at $10 in the report published on January 29th of the previous year.
AWH Trading at -2.03% from the 50-Day Moving Average
After a stumble in the market that brought AWH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -84.89% of loss for the given period.
Volatility was left at 8.56%, however, over the last 30 days, the volatility rate increased by 8.98%, as shares surge +10.85% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -20.26% lower at present.
During the last 5 trading sessions, AWH rose by +13.62%, which changed the moving average for the period of 200-days by -77.72% in comparison to the 20-day moving average, which settled at $0.8097. In addition, Aspira Women’s Health Inc saw -77.72% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AWH starting from Sandford Nicole, who purchase 9,493 shares at the price of $2.42 back on May 31 ’24. After this action, Sandford Nicole now owns 70,596 shares of Aspira Women’s Health Inc, valued at $22,973 using the latest closing price.
Merchant Minh Hoang, the Secretary & General Counsel of Aspira Women’s Health Inc, sale 980 shares at $3.37 during a trade that took place back on Dec 06 ’23, which means that Merchant Minh Hoang is holding 0 shares at $3,303 based on the most recent closing price.
Stock Fundamentals for AWH
Current profitability levels for the company are sitting at:
- -1.94 for the present operating margin
- 0.58 for the gross margin
The net margin for Aspira Women’s Health Inc stands at -1.79. The total capital return value is set at 11.59. Equity return is now at value -701.30, with -273.16 for asset returns.
Based on Aspira Women’s Health Inc (AWH), the company’s capital structure generated -1.08 points at debt to capital in total, while cash flow to debt ratio is standing at -7.77. The debt to equity ratio resting at -0.52. The interest coverage ratio of the stock is 598.41.
Currently, EBITDA for the company is -18.65 million with net debt to EBITDA at -0.08. When we switch over and look at the enterprise to sales, we see a ratio of 1.79. The receivables turnover for the company is 6.18for trailing twelve months and the total asset turnover is 2.25. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.60.
Conclusion
To sum up, Aspira Women’s Health Inc (AWH) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
